SAM
MRTX

Silphium Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Silphium Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,687
Closed -$280K – 155
2018
Q2 		$280K Buy
+5,687
New +$280K 0.09% 71